TRex Bio, Inc.
corporate_fare Company Profile
TRex Bio, Inc. (NASDAQ:TRXB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for TRXB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-16, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 7/10. Recent SEC coverage for TRXB spans SCHEDULE 13D.
Recent high-impact activity:
- Eli Lilly Discloses 19.9% Stake in TRex Bio Post-IPO, Flags Strategic Discussions
- Trexbio Prices IPO at $14, Raising $116.7M
Short Interest & Short Volume
On October 20, 2026, 30.6% of TRXB volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.